Phibro Animal Health (PAHC) Misses Q1 EPS by 2c, Revenues Miss; FY18 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
November 6, 2018 4:15 PM ESTTEANECK, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its first quarter ended September 30, 2018, and presented updated financial guidance for the fiscal year.
Highlights for the September 2018 quarter (compared to the September 2017 quarter)
Net sales of $200 million, an increase of $7 million, or 3%Net income of $16 million, an increase of 3%Diluted EPS of $0.40, an increase of $0.01, or 3%Adjusted EBITDA of $30 million, even with the prior yearAdjusted diluted EPS of $0.39, an increase of $0.01, or... More